共 42 条
- [42] An analysis of the cost savings achieved through practice of vial sharing for patients on azacitidine (Vidaza®) treatment for myelodysplastic syndromes (MDS), chronic myelomonocytic leukaemia (CMML with 10-29% blasts) and acute myeloid leukaemia (AML with 20-30% blasts) in a district general hospital (DGH) haematology unit over a 2 years period BRITISH JOURNAL OF HAEMATOLOGY, 2016, 173 : 123 - 124